SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
31 hedge funds and large institutions have $56.7M invested in Sinovac Biotech, Ltd in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
56% less capital invested
Capital invested by funds: $127M → $56.7M (-$70.8M)
Holders
31
Holding in Top 10
1
Calls
$776K
Puts
$265K
Top Buyers
| 1 | +$4.08M | |
| 2 | +$1.36M | |
| 3 | +$380K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$324K |
| 5 |
Barclays
London,
United Kingdom
|
+$192K |
Top Sellers
| 1 | -$4.93M | |
| 2 | -$3.84M | |
| 3 | -$699K | |
| 4 |
Millennium Management
New York
|
-$409K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$241K |